Der Browser den Sie verwenden ist sehr alt.

Wir können daher nicht sicherstellen, dass jede Funktion (Gestaltung, Bilder und zusätzliche Funktionen) dieser Internetseite im vollen Umfang zur Verfügung steht. Bitte nutzen Sie eine aktuellere Browserversion.
Wir bitten um Ihr Verständnis.
Startseite > Studien + Kooperationen > Publikationen


1: Scheinhardt MO, Lerman T, König IR, Griesinger G. Reply: Ovarian response and its prediction are relevant. Hum Reprod. 2019 Jan 11. doi: 10.1093/humrep/dey380. [Epub ahead of print] PubMed PMID: 30649363.

2: von Wolff M, Fäh M, Roumet M, Mitter V, Stute P, Griesinger G, Kohl Schwartz A. Thin Endometrium Is Also Associated With Lower Clinical Pregnancy Rate in Unstimulated Menstrual Cycles: A Study Based on Natural Cycle IVF. Front Endocrinol (Lausanne). 2018 Dec 20;9:776. doi: 10.3389/fendo.2018.00776. eCollection 2018. PubMed PMID: 30619099; PubMed Central PMCID: PMC6306415.

3: Griesinger G, Tournaye H, Macklon N, Petraglia F, Arck P, Blockeel C, van Amsterdam P, Pexman-Fieth C, Fauser BC. Dydrogesterone: pharmacological profile and mechanism of action as luteal phase support in assisted reproduction. Reprod Biomed Online. 2019 Feb;38(2):249-259. doi: 10.1016/j.rbmo.2018.11.017. Epub 2018 Dec 15. Review. PubMed PMID: 30595525.

4: Sexty RE, Griesinger G, Kayser J, Lallinger M, Rösner S, Strowitzki T, Toth B, Wischmann T. Psychometric characteristics of the FertiQoL questionnaire in a German sample of infertile individuals and couples. Health Qual Life Outcomes. 2018 Dec 17;16(1):233. doi: 10.1186/s12955-018-1058-9. PubMed PMID: 30558633; PubMed Central PMCID: PMC6296013.

5: Griesinger G, Teal V, McCrary Sisk C, Ruman J. Comparison of the follicular output rate after controlled ovarian stimulation with daily recombinant follicle-stimulating hormone versus corifollitropin alfa. Eur J Obstet Gynecol Reprod Biol. 2019 Jan;232:101-105. doi: 10.1016/j.ejogrb.2018.11.002. Epub 2018 Nov 5. PubMed PMID: 30529793.

6: Cirkel C, König IR, Schultze-Mosgau A, Beck E, Neumann K, Griesinger G. The use of intracytoplasmic sperm injection is associated with a shift in the secondary sex ratio. Reprod Biomed Online. 2018 Dec;37(6):703-708. doi: 10.1016/j.rbmo.2018.09.009. Epub 2018 Oct 6. PubMed PMID: 30385144.

7: Griesinger G, Blockeel C, Sukhikh GT, Patki A, Dhorepatil B, Yang DZ, Chen ZJ, Kahler E, Pexman-Fieth C, Tournaye H. Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial. Hum Reprod. 2018 Dec 1;33(12):2212-2221. doi: 10.1093/humrep/dey306. PubMed PMID: 30304457; PubMed Central PMCID: PMC6238366.

8: Verpoest W, Staessen C, Bossuyt PM, Goossens V, Altarescu G, Bonduelle M, Devesa M, Eldar-Geva T, Gianaroli L, Griesinger G, Kakourou G, Kokkali G, Liebenthron J, Magli MC, Parriego M, Schmutzler AG, Tobler M, van der Ven K, Geraedts J, Sermon K. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Hum Reprod. 2018 Sep 1;33(9):1767-1776. doi: 10.1093/humrep/dey262. PubMed PMID: 30085138.

9: Scheinhardt MO, Lerman T, König IR, Griesinger G. Performance of prognostic modelling of high and low ovarian response to ovarian stimulation for IVF. Hum Reprod. 2018 Jul 10. doi: 10.1093/humrep/dey236. [Epub ahead of print] PubMed PMID: 30007353.

10: Neumann K, Kayser J, Depenbusch M, Schultze-Mosgau A, Griesinger G. Can a quality-of-life assessment assist in identifying women at risk of prematurely discontinuing IVF treatment? A prospective cohort study utilizing the FertiQoL questionnaire. Arch Gynecol Obstet. 2018 Jul;298(1):223-229. doi: 10.1007/s00404-018-4797-2. Epub 2018 Jun 4. PubMed PMID: 29869088.

11: Griesinger G, Blockeel C, Tournaye H. Oral dydrogesterone for luteal phase support in fresh in vitro fertilization cycles: a new standard? Fertil Steril. 2018 May;109(5):756-762. doi: 10.1016/j.fertnstert.2018.03.034. Review. PubMed PMID: 29778368.

12: Griesinger G, Meldrum D. Introduction: Management of the luteal phase in assisted reproductive technology. Fertil Steril. 2018 May;109(5):747-748. doi: 10.1016/j.fertnstert.2018.02.009. PubMed PMID: 29778366.

13: Neumann K, Griesinger G. Follicular flushing in patients with poor ovarian response: a systematic review and meta-analysis. Reprod Biomed Online. 2018 Apr;36(4):408-415. doi: 10.1016/j.rbmo.2017.12.014. Epub 2017 Dec 29. Review. PubMed PMID: 29336996.

14: Graspeuntner S, Bohlmann MK, Gillmann K, Speer R, Kuenzel S, Mark H, Hoellen F, Lettau R, Griesinger G, König IR, Baines JF, Rupp J. Microbiota-based analysis reveals specific bacterial traits and a novel strategy for the diagnosis of infectious infertility. PLoS One. 2018 Jan 9;13(1):e0191047. doi: 10.1371/journal.pone.0191047. eCollection 2018. PubMed PMID: 29315330; PubMed Central PMCID: PMC5760088.

15: Kolibianakis EM, Griesinger G, Venetis CA. GnRH antagonists vs. long GnRH agonists in IVF: significant flaws in a meta-analysis lead to invalid conclusions. Hum Reprod Update. 2017 Dec 29. doi: 10.1093/humupd/dmx037. [Epub ahead of print] PubMed PMID: 29300885.

16: Golakov M, Depenbusch M, Schultze-Mosgau A, Schoepper B, Hajek J, Neumann K, Griesinger G. What is the net effect of introducing vitrification for cryopreservation of surplus 2PN oocytes in an IVF program? Arch Gynecol Obstet. 2018 Feb;297(2):529-537. doi: 10.1007/s00404-017-4606-3. Epub 2017 Dec 11. PubMed PMID: 29230537.

17: Tournaye H, Sukhikh GT, Kahler E, Griesinger G. A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization. Hum Reprod. 2017 Oct 1;32(10):2152. doi: 10.1093/humrep/dex266. PubMed PMID: 28938733.

18: Tournaye H, Sukhikh GT, Kahler E, Griesinger G. A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization. Hum Reprod. 2017 May 1;32(5):1019-1027. doi: 10.1093/humrep/dex023. Erratum in: Hum Reprod. 2017 Oct 1;32(10):2152. PubMed PMID: 28333318; PubMed Central PMCID: PMC5400051.

19: von Horn K, Depenbusch M, Schultze-Mosgau A, Griesinger G. Randomized, open trial comparing a modified double-lumen needle follicular flushing system with a single-lumen aspiration needle in IVF patients with poor ovarian response. Hum Reprod. 2017 Apr 1;32(4):832-835. doi: 10.1093/humrep/dex019. PubMed PMID: 28333185.

20: Lerman T, Depenbusch M, Schultze-Mosgau A, von Otte S, Scheinhardt M, Koenig I, Kamischke A, Macek M, Schwennicke A, Segerer S, Griesinger G. Ovarian response to 150 µg corifollitropin alfa in a GnRH-antagonist multiple-dose protocol: a prospective cohort study. Reprod Biomed Online. 2017 May;34(5):534-540. doi: 10.1016/j.rbmo.2017.02.012. Epub 2017 Mar 2. PubMed PMID: 28285952.

21: Van der Ven H, Liebenthron J, Beckmann M, Toth B, Korell M, Krüssel J, Frambach T, Kupka M, Hohl MK, Winkler-Crepaz K, Seitz S, Dogan A, Griesinger G, Häberlin F, Henes M, Schwab R, Sütterlin M, von Wolff M, Dittrich R; FertiPROTEKT network. Ninety-five orthotopic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network: tissue activity, pregnancy and delivery rates. Hum Reprod. 2016 Sep;31(9):2031-41. doi: 10.1093/humrep/dew165. Epub 2016 Jul 4. PubMed PMID: 27378768.

22: Griesinger G. Reply: Skating on thin ice when using the outcome implantation rate for evaluating the utility of embryo selection techniques such as PGS. Hum Reprod. 2016 Aug;31(8):1927-8. doi: 10.1093/humrep/dew139. Epub 2016 Jun 14. PubMed PMID: 27301364.

23: Beyer DA, Griesinger G. Vitrified-warmed embryo transfer is associated with mean higher singleton birth weight compared to fresh embryo transfer. Eur J Obstet Gynecol Reprod Biol. 2016 Aug;203:104-7. doi: 10.1016/j.ejogrb.2016.05.041. Epub 2016 May 26. PubMed PMID: 27267871.

 24: Sermon K, Capalbo A, Cohen J, Coonen E, De Rycke M, De Vos A, Delhanty J, Fiorentino F, Gleicher N, Griesinger G, Grifo J, Handyside A, Harper J, Kokkali G, Mastenbroek S, Meldrum D, Meseguer M, Montag M, Munné S, Rienzi L, Rubio C, Scott K, Scott R, Simon C, Swain J, Treff N, Ubaldi F, Vassena R, Vermeesch JR, Verpoest W, Wells D, Geraedts J. The why, the how and the when of PGS 2.0: current practices and expert opinions of fertility specialists, molecular biologists, and embryologists. Mol Hum Reprod. 2016 Aug;22(8):845-57. doi: 10.1093/molehr/gaw034. Epub 2016 Jun 2. Review. PubMed PMID: 27256483; PubMed Central PMCID: PMC4986417.

25: Griesinger G, Boostanfar R, Gordon K, Gates D, McCrary Sisk C, Stegmann BJ. Corifollitropin alfa versus recombinant follicle-stimulating hormone: an individual patient data meta-analysis. Reprod Biomed Online. 2016 Jul;33(1):56-60. doi: 10.1016/j.rbmo.2016.04.005. Epub 2016 Apr 20. PubMed PMID: 27178762.

26: Pereira I, von Horn K, Depenbusch M, Schultze-Mosgau A, Griesinger G. Self-operated endovaginal telemonitoring: a prospective, clinical validation study. Fertil Steril. 2016 Aug;106(2):306-310.e1. doi: 10.1016/j.fertnstert.2016.03.043. Epub 2016 Apr 16. PubMed PMID: 27090865.

27: Doblinger J, Cometti B, Trevisan S, Griesinger G. Subcutaneous Progesterone Is Effective and Safe for Luteal Phase Support in IVF: An Individual Patient Data Meta-Analysis of the Phase III Trials. PLoS One. 2016 Mar 18;11(3):e0151388. doi: 10.1371/journal.pone.0151388. eCollection 2016. PubMed PMID: 26991890; PubMed Central PMCID: PMC4798618.

28: Griesinger G, Verweij PJ, Gates D, Devroey P, Gordon K, Stegmann BJ, Tarlatzis BC. Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist Protocol. PLoS One. 2016 Mar 7;11(3):e0149615. doi: 10.1371/journal.pone.0149615. eCollection 2016. PubMed PMID: 26950065; PubMed Central PMCID: PMC4780699.

29: Schaller MA, Griesinger G, Banz-Jansen C. Women show a higher level of anxiety during IVF treatment than men and hold different concerns: a cohort study. Arch Gynecol Obstet. 2016 May;293(5):1137-45. doi: 10.1007/s00404-016-4033-x. Epub 2016 Feb 16. PubMed PMID: 26884350.

30: Griesinger G. Beware of the 'implantation rate'! Why the outcome parameter 'implantation rate' should be abandoned from infertility research. Hum Reprod. 2016 Feb;31(2):249-51. doi: 10.1093/humrep/dev322. Epub 2016 Jan 2. PubMed PMID: 26724801.

31: Youssef MA, Van der Veen F, Al-Inany HG, Mochtar MH, Griesinger G, Aboulfoutoh I, van Wely M. The updated Cochrane review 2014 on GnRH agonist trigger: an indispensable piece of information for the clinician. Reprod Biomed Online. 2016 Feb;32(2):259-60. doi: 10.1016/j.rbmo.2015.11.006. Epub 2015 Nov 23. PubMed PMID: 26655648.

 32: Rombauts L, Lambalk CB, Schultze-Mosgau A, van Kuijk J, Verweij P, Gates D, Gordon K, Griesinger G. Intercycle variability of the ovarian response in patients undergoing repeated stimulation with corifollitropin alfa in a gonadotropin-releasing hormone antagonist protocol. Fertil Steril. 2015 Oct;104(4):884-890.e2. doi: 10.1016/j.fertnstert.2015.06.027. Epub 2015 Jul 15. PubMed PMID: 26187300.

33: Griesinger G, Venetis CA, Tarlatzis B, Kolibianakis EM. To pill or not to pill in GnRH-antagonist cycles: the answer is in the data already! Reprod Biomed Online. 2015 Jul;31(1):6-8. doi: 10.1016/j.rbmo.2015.04.001. Epub 2015 Apr 9. PubMed PMID: 25985996.

34: Youssef MA, Van der Veen F, Al-Inany HG, Mochtar MH, Griesinger G, Nagi Mohesen M, Aboulfoutouh I, van Wely M. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology. Cochrane Database Syst Rev. 2014 Oct 31;(10):CD008046. doi: 10.1002/14651858.CD008046.pub4. Review. PubMed PMID: 25358904.

 35: Klocke S, Bündgen N, Köster F, Eichenlaub-Ritter U, Griesinger G. Slow-freezing versus vitrification for human ovarian tissue cryopreservation. Arch Gynecol Obstet. 2015 Feb;291(2):419-26. doi: 10.1007/s00404-014-3390-6. Epub 2014 Aug 13. PubMed PMID: 25115279.

36: Kupka MS, Ferraretti AP, de Mouzon J, Erb K, D'Hooghe T, Castilla JA, Calhaz-Jorge C, De Geyter C, Goossens V; European IVF-Monitoring Consortium, for the European Society of Human Reproduction and Embryology. Assisted reproductive technology in Europe, 2010: results generated from European registers by ESHRE†. Hum Reprod. 2014 Oct 10;29(10):2099-113. doi: 10.1093/humrep/deu175. Epub 2014 Jul 27. PubMed PMID: 25069504.

37: Klocke S, Tappehorn C, Griesinger G. Effects of supra-zero storage on human ovarian cortex prior to vitrification-warming. Reprod Biomed Online. 2014 Aug;29(2):251-8. doi: 10.1016/j.rbmo.2014.03.025. Epub 2014 May 16. PubMed PMID: 24953192.

38: Griesinger G. Commentary on 'Effect of ethnicity on live birth rates after in vitro fertilisation or intracytoplasmic sperm injection treatment'. BJOG. 2014 Feb;121(3):306-7. PubMed PMID: 24575433.

39: Dewailly D, Andersen CY, Balen A, Broekmans F, Dilaver N, Fanchin R, Griesinger G, Kelsey TW, La Marca A, Lambalk C, Mason H, Nelson SM, Visser JA, Wallace WH, Anderson RA. The physiology and clinical utility of anti-Mullerian hormone in women. Hum Reprod Update. 2014 May-Jun;20(3):370-85. doi: 10.1093/humupd/dmt062. Epub 2014 Jan 14. Review. Erratum in: Hum Reprod Update. 2014 Sep-Oct;20(5):804. PubMed PMID: 24430863.

40: La Marca A, Grisendi V, Griesinger G. How Much Does AMH Really Vary in Normal Women? Int J Endocrinol. 2013;2013:959487. doi: 10.1155/2013/959487. Epub 2013 Nov 19. Review. PubMed PMID: 24348558; PubMed Central PMCID: PMC3852815.

41: Griesinger G, Mannaerts B, Andersen CY, Witjes H, Kolibianakis EM, Gordon K. Reply of the authors. Fertil Steril. 2014 Jan;101(1):e5-6. doi: 10.1016/j.fertnstert.2013.10.037. Epub 2013 Nov 26. PubMed PMID: 24289995.

42: Lockwood G, Griesinger G, Cometti B; 13 European Centers. Subcutaneous progesterone versus vaginal progesterone gel for luteal phase support in in vitro fertilization: a noninferiority randomized controlled study. Fertil Steril. 2014 Jan;101(1):112-119.e3. doi: 10.1016/j.fertnstert.2013.09.010. Epub 2013 Oct 17. PubMed PMID: 24140033.

43: Griesinger G, Mannaerts B, Andersen CY, Witjes H, Kolibianakis EM, Gordon K. Progesterone elevation does not compromise pregnancy rates in high responders: a pooled analysis of in vitro fertilization patients treated with recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in six trials. Fertil Steril. 2013 Dec;100(6):1622-8.e1-3. doi: 10.1016/j.fertnstert.2013.08.045. Epub 2013 Sep 29. PubMed PMID: 24083873.

44: von Wolff M, Rösner S, Germeyer A, Jauckus J, Griesinger G, Strowitzki T. Intrauterine instillation of diluted seminal plasma at oocyte pick-up does not increase the IVF pregnancy rate: a double-blind, placebo controlled, randomized study. Hum Reprod. 2013 Dec;28(12):3247-52. doi: 10.1093/humrep/det351. Epub 2013 Sep 17. PubMed PMID: 24045780.

45: Hoellen F, Griesinger G, Bohlmann MK. Therapeutic drugs in the treatment of symptomatic uterine fibroids. Expert Opin Pharmacother. 2013 Oct;14(15):2079-85. doi: 10.1517/14656566.2013.825607. Epub 2013 Aug 6. Review. PubMed PMID: 23914973.

46: Buendgen NK, Schultze-Mosgau A, Cordes T, Diedrich K, Griesinger G. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study. Arch Gynecol Obstet. 2013 Oct;288(4):901-4. doi: 10.1007/s00404-013-2794-z. Epub 2013 Apr 3. PubMed PMID: 23545834.

47: Fatemi HM, Doody K, Griesinger G, Witjes H, Mannaerts B. High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates in a GnRH-antagonist protocol. Hum Reprod. 2013 Feb;28(2):442-52. doi: 10.1093/humrep/des389. Epub 2012 Nov 7. Erratum in: Hum Reprod. 2014 Sep;29(9):2074-5. PubMed PMID: 23136144.

48: Griesinger G, Dafopoulos K, Buendgen N, Cascorbi I, Georgoulias P, Zavos A, Messini CI, Messinis IE. Elimination half-life of anti-Müllerian hormone. J Clin Endocrinol Metab. 2012 Jun;97(6):2160-3. doi: 10.1210/jc.2012-1070. Epub 2012 Mar 22. PubMed PMID: 22442264.

49: Griesinger G, Kolibianakis EM. Can oestradiol pretreatment be used to reliably avoid weekend oocyte retrievals? Reprod Biomed Online. 2012 May;24(5):487-9. doi: 10.1016/j.rbmo.2012.01.026. Epub 2012 Feb 3. PubMed PMID: 22414373.

50: Tarlatzis BC, Griesinger G, Leader A, Rombauts L, Ijzerman-Boon PC, Mannaerts BM. Comparative incidence of ovarian hyperstimulation syndrome following ovarian stimulation with corifollitropin alfa or recombinant FSH. Reprod Biomed Online. 2012 Apr;24(4):410-9. doi: 10.1016/j.rbmo.2012.01.005. Epub 2012 Jan 24. PubMed PMID: 22386594.

51: Kolibianakis EM, Griesinger G, Venetis CA. GnRH agonist for triggering final oocyte maturation: time for a critical evaluation of data. Hum Reprod Update. 2012 Mar-Apr;18(2):228-9; author reply 229-30. doi: 10.1093/humupd/dmr055. Epub 2012 Jan 24. PubMed PMID: 22279109.

52: Griesinger G, Shapiro DB, Kolibianakis EM, Witjes H, Mannaerts BM. No association between endogenous LH and pregnancy in a GnRH antagonist protocol: part II, recombinant FSH. Reprod Biomed Online. 2011 Oct;23(4):457-65. doi: 10.1016/j.rbmo.2011.06.016. Epub 2011 Jul 7. PubMed PMID: 21843970.

53: Griesinger G, Shapiro DB. Luteinizing hormone add-back: is it needed in controlled ovarian stimulation, and if so, when? J Reprod Med. 2011 Jul-Aug;56(7-8):279-300. Review. PubMed PMID: 21838158.

54: Griesinger G, Schultz L, Bauer T, Broessner A, Frambach T, Kissler S. Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a "freeze-all" strategy: a prospective multicentric study. Fertil Steril. 2011 May;95(6):2029-33, 2033.e1. doi: 10.1016/j.fertnstert.2011.01.163. Epub 2011 Mar 2. PubMed PMID: 21371705.

55: Griesinger G. Editorial commentary: is it time to abandon progesterone supplementation of early pregnancy after IVF? Hum Reprod. 2011 May;26(5):1017-9. doi: 10.1093/humrep/der013. Epub 2011 Feb 4. PubMed PMID: 21296804.

56: Diedrich K, Fauser BC, Devroey P; Evian Annual Reproduction (EVAR) Workshop Group 2009. Cancer and fertility: strategies to preserve fertility. Reprod Biomed Online. 2011 Mar;22(3):232-48. doi: 10.1016/j.rbmo.2010.11.001. Epub 2010 Nov 13. Review. PubMed PMID: 21269884.

57: Youssef MA, Van der Veen F, Al-Inany HG, Griesinger G, Mochtar MH, Aboulfoutouh I, Khattab SM, van Wely M. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles. Cochrane Database Syst Rev. 2011 Jan 19;(1):CD008046. doi: 10.1002/14651858.CD008046.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;10:CD008046. PubMed PMID: 21249699.

58: Beyer DA, Amari F, Thill M, Schultze-Mosgau A, Al-Hasani S, Diedrich K, Griesinger G. Emerging gonadotropin-releasing hormone agonists. Expert Opin Emerg Drugs. 2011 Jun;16(2):323-40. doi: 10.1517/14728214.2010.547472. Epub 2011 Jan 19. Review. PubMed PMID: 21244327.

59: Griesinger G, Berndt H, Schultz L, Schultze-Mosgau A, Diedrich K, von Otte S. Intensified ovarian stimulation in a GnRH antagonist protocol with agonist triggering: a prospective, clinical feasibility study. Reprod Biomed Online. 2011 Feb;22(2):133-9. doi: 10.1016/j.rbmo.2010.10.017. Epub 2010 Nov 12. PubMed PMID: 21227753.

60: Griesinger G. Ovarian hyperstimulation syndrome prevention strategies: use of gonadotropin-releasing hormone antagonists. Semin Reprod Med. 2010 Nov;28(6):493-9. doi: 10.1055/s-0030-1265676. Epub 2010 Nov 16. Review. PubMed PMID: 21082508.

61: Youssef MA, Van der Veen F, Al-Inany HG, Griesinger G, Mochtar MH, van Wely M. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles. Cochrane Database Syst Rev. 2010 Nov 10;(11):CD008046. doi: 10.1002/14651858.CD008046.pub2. Review. Update in: Cochrane Database Syst Rev. 2011;(1):CD008046. PubMed PMID: 21069701.

62: Cordes T, Schultze-Mosgau A, Diedrich K, Griesinger G. Ongoing pregnancy after human menopausal gonadotropin stimulation and timed intercourse in a 40-year-old woman with undetectable antimüllerian hormone levels. Fertil Steril. 2010 Sep;94(4):e70; author reply e71-2. doi: 10.1016/j.fertnstert.2010.06.073. Epub 2010 Aug 9. PubMed PMID: 20691437.

63: Griesinger G, Kolibianakis EM, Venetis C, Diedrich K, Tarlatzis B. Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood in gonadotropin-releasing hormone antagonist cycles: an updated meta-analysis. Fertil Steril. 2010 Nov;94(6):2382-4. doi: 10.1016/j.fertnstert.2010.04.025. Epub 2010 May 26. PubMed PMID: 20537631.

64: Guenova E, Volz T, Eichner M, Hoetzenecker W, Caroli U, Griesinger G, Burow G, Mitev V, Biedermann T. Basal serum tryptase as risk assessment for severe Hymenoptera sting reactions in elderly. Allergy. 2010 Jul;65(7):919-23. doi: 10.1111/j.1398-9995.2009.02302.x. Epub 2010 Feb 1. PubMed PMID: 20121769.

65: Hornemann A, Diedrich K, Beyer D, Dawson A, Luedders DW, Thill M, Griesinger G, Bohlmann MK. [Spontaneously conceived twins and twins after ART: are there any differences regarding direct financial costs of delivery]. Z Geburtshilfe Neonatol. 2009 Dec;213(6):267-71. doi: 10.1055/s-0029-1241883. Epub 2010 Jan 22. German. PubMed PMID: 20099214.

66: Bohlmann MK, Fritzsching B, Luedders DW, Hornemann A, Göpel W, Pöschl J, Diedrich K, Griesinger G. [Impact of assisted reproduction on obstetrics and neonatology]. Z Geburtshilfe Neonatol. 2009 Dec;213(6):221-7. doi: 10.1055/s-0029-1238275. Epub 2010 Jan 22. Review. German. PubMed PMID: 20099209.

67: Griesinger G, Berndt H, Schultz L, Depenbusch M, Schultze-Mosgau A. Cumulative live birth rates after GnRH-agonist triggering of final oocyte maturation in patients at risk of OHSS: a prospective, clinical cohort study. Eur J Obstet Gynecol Reprod Biol. 2010 Apr;149(2):190-4. doi: 10.1016/j.ejogrb.2009.12.030. Epub 2010 Jan 25. PubMed PMID: 20097467.

68: Fatemi HM, Kyrou D, Bourgain C, Van den Abbeel E, Griesinger G, Devroey P. Cryopreserved-thawed human embryo transfer: spontaneous natural cycle is superior to human chorionic gonadotropin-induced natural cycle. Fertil Steril. 2010 Nov;94(6):2054-8. doi: 10.1016/j.fertnstert.2009.11.036. Epub 2010 Jan 25. PubMed PMID: 20097333.

69: Depenbusch M, Diedrich K, Griesinger G. Ovarian hyperresponse to luteal phase GnRH-agonist administration. Arch Gynecol Obstet. 2010 Jun;281(6):1071-2. doi: 10.1007/s00404-009-1309-4. Epub 2009 Dec 4. PubMed PMID: 19960348.

70: Beyer DA, Amari F, Diedrich K, Griesinger G. [Significance of reproductive medicine in regard to judicial and ethical concerns in Germany]. Ther Umsch. 2009 Dec;66(12):819-23. doi: 10.1024/0040-5930.66.12.819. Review. German. PubMed PMID: 19950061.

71: Tierling S, Souren NY, Gries J, Loporto C, Groth M, Lutsik P, Neitzel H, Utz-Billing I, Gillessen-Kaesbach G, Kentenich H, Griesinger G, Sperling K, Schwinger E, Walter J. Assisted reproductive technologies do not enhance the variability of DNA methylation imprints in human. J Med Genet. 2010 Jun;47(6):371-6. doi: 10.1136/jmg.2009.073189. Epub 2009 Nov 30. PubMed PMID: 19948534.

72: Griesinger G, Schultz L, Diedrich K. Publication productivity in IVF in Europe, 1990-2006. Reprod Biomed Online. 2009 Oct;19(4):452-5. PubMed PMID: 19909584.

73: Griesinger G, Bündgen N, Salmen D, Schwinger E, Gillessen-Kaesbach G, Diedrich K. Polar body biopsy in the diagnosis of monogenic diseases: the birth of three healthy children. Dtsch Arztebl Int. 2009 Aug;106(33):533-8. doi: 10.3238/arztebl.2009.0533. Epub 2009 Aug 14. PubMed PMID: 19738920; PubMed Central PMCID: PMC2737433.

74: Connolly MP, Griesinger G, Ledger W, Postma MJ. The impact of introducing patient co-payments in Germany on the use of IVF and ICSI: a price-elasticity of demand assessment. Hum Reprod. 2009 Nov;24(11):2796-800. doi: 10.1093/humrep/dep260. Epub 2009 Jul 22. PubMed PMID: 19625316.

75: Kolibianakis EM, Venetis CA, Diedrich K, Tarlatzis BC, Griesinger G. Addition of growth hormone to gonadotrophins in ovarian stimulation of poor responders treated by in-vitro fertilization: a systematic review and meta-analysis. Hum Reprod Update. 2009 Nov-Dec;15(6):613-22. doi: 10.1093/humupd/dmp026. Epub 2009 Jun 26. Review. PubMed PMID: 19561136.

76: Devroey P, Fauser BC, Diedrich K; Evian Annual Reproduction (EVAR) Workshop Group 2008. Approaches to improve the diagnosis and management of infertility. Hum Reprod Update. 2009 Jul-Aug;15(4):391-408. doi: 10.1093/humupd/dmp012. Epub 2009 Apr 20. Review. PubMed PMID: 19380415; PubMed Central PMCID: PMC2691653.

77: Griesinger G, Diedrich K. [New developments in ovarian stimulation]. Gynakol Geburtshilfliche Rundsch. 2009;49(2):55-61. doi: 10.1159/000197903. Epub 2009 Mar 25. Review. German. PubMed PMID: 19346749.

78: Devroey P, Aboulghar M, Garcia-Velasco J, Griesinger G, Humaidan P, Kolibianakis E, Ledger W, Tomás C, Fauser BC. Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment. Hum Reprod. 2009 Apr;24(4):764-74. doi: 10.1093/humrep/den468. Epub 2009 Jan 19. Review. PubMed PMID: 19153090.

79: Griesinger G, Kolibianakis EM, Diedrich K, Ludwig M. Ovarian stimulation for IVF has no quantitative association with birthweight: a registry study. Hum Reprod. 2008 Nov;23(11):2549-54. doi: 10.1093/humrep/den286. Epub 2008 Aug 6. PubMed PMID: 18684734.

80: Kolibianakis EM, Venetis CA, Papanikolaou EG, Diedrich K, Tarlatzis BC, Griesinger G. Estrogen addition to progesterone for luteal phase support in cycles stimulated with GnRH analogues and gonadotrophins for IVF: a systematic review and meta-analysis. Hum Reprod. 2008 Jun;23(6):1346-54. doi: 10.1093/humrep/den115. Epub 2008 Apr 11. Review. PubMed PMID: 18408017.

81: Griesinger G, von Otte S, Schultze-Mosgau A, Diedrich K, Schröer A. Follicular and endocrine response to anastrozole versus clomiphene citrate administered in follicular phase to normoovulatory women: a randomized comparison. Fertil Steril. 2009 May;91(5):1831-6. doi: 10.1016/j.fertnstert.2008.01.091. Epub 2008 Apr 18. PubMed PMID: 18394612.

82: Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod. 2008 Mar;23(3):462-77. doi: 10.1093/humrep/dem426. Erratum in: Hum Reprod. 2008 Jun;23(6):1474. PubMed PMID: 18308833.

83: Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril. 2008 Mar;89(3):505-22. doi: 10.1016/j.fertnstert.2007.09.041. Epub 2008 Feb 20. PubMed PMID: 18243179.

84: Griesinger G, Venetis CA, Marx T, Diedrich K, Tarlatzis BC, Kolibianakis EM. Oral contraceptive pill pretreatment in ovarian stimulation with GnRH antagonists for IVF: a systematic review and meta-analysis. Fertil Steril. 2008 Oct;90(4):1055-63. Epub 2007 Dec 3. Review. PubMed PMID: 18054003.

85: Griesinger G, Diedrich K, Altgassen C. Stronger reduction of assisted reproduction technique treatment cycle numbers in economically weak geographical regions following the German healthcare modernization law in 2004. Hum Reprod. 2007 Nov;22(11):3027-30. Epub 2007 Sep 19. PubMed PMID: 17884804.

86: Griesinger G, Weig M, Schroer A, Diedrich K, Kolibianakis EM. Mid-cycle serum levels of endogenous LH are not associated with the likelihood of pregnancy in artificial frozen-thawed embryo transfer cycles without pituitary suppression. Hum Reprod. 2007 Oct;22(10):2589-93. Epub 2007 Jul 25. PubMed PMID: 17652451.

87: Kolibianakis EM, Kalogeropoulou L, Griesinger G, Papanikolaou EG, Papadimas J, Bontis J, Tarlatzis BC. Among patients treated with FSH and GnRH analogues for in vitro fertilization, is the addition of recombinant LH associated with the probability of live birth? A systematic review and meta-analysis. Hum Reprod Update. 2007 Sep-Oct;13(5):445-52. Epub 2007 Jun 23. Review. PubMed PMID: 17586849.

88: Diedrich K, Fauser BC, Devroey P, Griesinger G; Evian Annual Reproduction (EVAR) Workshop Group. The role of the endometrium and embryo in human implantation. Hum Reprod Update. 2007 Jul-Aug;13(4):365-77. Epub 2007 Jun 4. Review. PubMed PMID: 17548368.

89: Rousseau K, Byrne C, Griesinger G, Leung A, Chung A, Hill AS, Swallow DM. Allelic association and recombination hotspots in the mucin gene (MUC) complex on chromosome 11p15.5. Ann Hum Genet. 2007 Sep;71(Pt 5):561-9. Epub 2007 May 29. PubMed PMID: 17535267.

90: Griesinger G, Kolibianakis EM, Papanikolaou EG, Diedrich K, Van Steirteghem A, Devroey P, Ejdrup Bredkjaer H, Humaidan P. Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles. Fertil Steril. 2007 Sep;88(3):616-21. Epub 2007 Apr 23. PubMed PMID: 17451691.

91: Griesinger G, Gille G, Klapp C, von Otte S, Diedrich K. Sexual behaviour and Chlamydia trachomatis infections in German female urban adolescents, 2004. Clin Microbiol Infect. 2007 Apr;13(4):436-9. PubMed PMID: 17359330.

92: Griesinger G, von Otte S, Schroer A, Ludwig AK, Diedrich K, Al-Hasani S, Schultze-Mosgau A. Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study. Hum Reprod. 2007 May;22(5):1348-52. Epub 2007 Feb 15. PubMed PMID: 17303632.

93: Villena-Heinsen C, Diesing D, Fischer D, Griesinger G, Maas N, Diedrich K, Friedrich M. Carcinosarcomas--a retrospective analysis of 21 patients. Anticancer Res. 2006 Nov-Dec;26(6C):4817-23. PubMed PMID: 17214346.

94: Griesinger G, Diedrich K, Tarlatzis BC, Kolibianakis EM. GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis. Reprod Biomed Online. 2006 Nov;13(5):628-38. PubMed PMID: 17169171.

95: Kolibianakis EM, Collins J, Tarlatzis BC, Devroey P, Diedrich K, Griesinger G. Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Hum Reprod Update. 2006 Nov-Dec;12(6):651-71. Epub 2006 Aug 18. Review. PubMed PMID: 16920869.

96: Ludwig AK, Glawatz M, Griesinger G, Diedrich K, Ludwig M. Perioperative and post-operative complications of transvaginal ultrasound-guided oocyte retrieval: prospective study of >1000 oocyte retrievals. Hum Reprod. 2006 Dec;21(12):3235-40. Epub 2006 Jul 27. PubMed PMID: 16877373.

97: Dawson A, Griesinger G, Diedrich K. Screening oocytes by polar body biopsy.Reprod Biomed Online. 2006 Jul;13(1):104-9. Review. PubMed PMID: 16820120.

98: Engel JB, Griesinger G, Schultze-Mosgau A, Felberbaum R, Diedrich K. GnRH agonists and antagonists in assisted reproduction: pregnancy rate. Reprod Biomed Online. 2006 Jul;13(1):84-7. PubMed PMID: 16820115.

99: Griesinger G, Diedrich K. Role of LH in ovarian stimulation: considerations. Reprod Biomed Online. 2006 Apr;12(4):404-6. Review. PubMed PMID: 16740210.

100: Griesinger G, Dawson A, Schultze-Mosgau A, Finas D, Diedrich K, Felberbaum R. Assessment of luteinizing hormone level in the gonadotropin-releasing hormone antagonist protocol. Fertil Steril. 2006 Mar;85(3):791-3. PubMed PMID: 16500366.

101: Tomi D, Schultze-Mosgau A, Eckhold J, Schopper B, Al-Hasani S, Steglich C, Gal A, Axt-Fliedner R, Schwinger E, Diedrich K, Griesinger G. First pregnancy and life after preimplantation genetic diagnosis by polar body analysis for mucopolysaccharidosis type I. Reprod Biomed Online. 2006 Feb;12(2):215-20. PubMed PMID: 16478590.

102: Griesinger G, Dafopoulos K, Schultze-Mosgau A, Jelkmann W, von Otte S, Diesing D, Diedrich K. Vascular endothelial growth factor response to exogenous chorionic gonadotropic hormone in the luteal phase of women with a history of severe ovarian hyperstimulation syndrome. Arch Gynecol Obstet. 2006 Apr;274(1):29-33. Epub 2006 Jan 12. PubMed PMID: 16408189.

103: Griesinger G, Diedrich K, Devroey P, Kolibianakis EM. GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis. Hum Reprod Update. 2006 Mar-Apr;12(2):159-68. Epub 2005 Oct 27. PubMed PMID: 16254001.

104: Schultze-Mosgau A, Griesinger G, Altgassen C, von Otte S, Hornung D, Diedrich K. New developments in the use of peptide gonadotropin-releasing hormone  antagonists versus agonists. Expert Opin Investig Drugs. 2005 Sep;14(9):1085-97. Review. PubMed PMID: 16144493.

105: Griesinger G, Felberbaum R, Diedrich K. GnRH-antagonists in reproductive medicine. Arch Gynecol Obstet. 2005 Dec;273(2):71-8. Epub 2005 Jul 1. Review. PubMed PMID: 15991015.

106: Kolibianakis EM, Schultze-Mosgau A, Schroer A, van Steirteghem A, Devroey P, Diedrich K, Griesinger G. A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists. Hum Reprod. 2005 Oct;20(10):2887-92. Epub 2005 Jun 24. PubMed PMID: 15979994.

107: Griesinger G, Felberbaum R, Diedrich K. GnRH antagonists in ovarian stimulation: a treatment regimen of clinicians' second choice? Data from the German national IVF registry. Hum Reprod. 2005 Sep;20(9):2373-5. Epub 2005 Jun 2. PubMed PMID: 15932915.

108: Griesinger G, Diedrich K, Edwards RG. Gonadotrophins--past, present and future. Reprod Biomed Online. 2005 Jun;10 Suppl 3:91-2. PubMed PMID: 23577420.

109: Felberbaum RE, Griesinger G, Finas D, Dawson A, Diedrich K. To agonize or antagonize in gonadotrophin stimulation cycles? Reprod Biomed Online. 2005 Jun;10 Suppl 3:33-6. PubMed PMID: 23577413.

 110: Dafopoulos K, Griesinger G, Schultze-Mosgau A, Orief Y, Schöpper B, Nikolettos N, Diedrich K, Al-Hasani S. Cumulative pregnancy rate after ICSI with cryopreserved testicular tissue in non-obstructive azoospermia. Reprod Biomed Online. 2005 Apr;10(4):461-6. PubMed PMID: 15901452.

111: Dafopoulos K, Griesinger G, Schultze-Mosgau A, Orief Y, Schöpper B, Nikolettos N, Diedrich K, Al-Hasani S. Factors affecting outcome after ICSI with spermatozoa retrieved from cryopreserved testicular tissue in non-obstructive azoospermia. Reprod Biomed Online. 2005 Apr;10(4):455-60. PubMed PMID: 15901451.

112: Tomi D, Griesinger G, Schultze-Mosgau A, Eckhold J, Schöpper B, Al-Hasani S, Diedrich K, Schwinger E. Polar body diagnosis for hemophilia a using multiplex PCR for linked polymorphic markers. J Histochem Cytochem. 2005 Mar;53(3):277-80. PubMed PMID: 15750001.

113: Griesinger G, Dafopoulos K, Schultze-Mosgau A, Schroder A, Felberbaum R, Diedrich K. Mayer-Rokitansky-Küster-Hauser syndrome associated with thrombocytopenia-absent radius syndrome. Fertil Steril. 2005 Feb;83(2):452-4. PubMed PMID: 15705390.

114: Griesinger G, Schultze-Mosgau A, Dafopoulos K, Schroeder A, Schroer A, von Otte S, Hornung D, Diedrich K, Felberbaum R. Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol. Hum Reprod. 2005 May;20(5):1200-6. Epub 2005 Jan 21. PubMed PMID: 15665010.

115: Griesinger G, Finas D, Alisch A, Roiha K, Schultze-Mosgau A, Schröder AK,Dafopoulos K, Diedrich K, Felberbaum R. FSH time-concentration profiles before and after administration of 0.25 mg cetrorelix in the gnRH-antagonist multiple-dose protocol for ovarian hyperstimulation. J Assist Reprod Genet. 2004 Jul;21(7):279-82. PubMed PMID: 15526986; PubMed Central PMCID: PMC3455183.

116: Griesinger G, Dafopoulos K, Schultze-Mosgau A, Felberbaum R, Diedrich K. What is the most relevant standard of success in assisted reproduction? Is BESST (birth emphasizing a successful singleton at term) truly the best? Hum Reprod. 2004 Jun;19(6):1239-41. Epub 2004 Apr 22. PubMed PMID: 15105385.

117: Griesinger G, Felberbaum RE, Schultze-Mosgau A, Diedrich K. Gonadotropin-releasing hormone antagonists for assisted reproductive techniques: are there clinical differences between agents? Drugs. 2004;64(6):563-75. Review. PubMed PMID: 15018588.

118: Griesinger G, Franke K, Kinast C, Kutzelnigg A, Riedinger S, Kulin S, Kaali SG, Feichtinger W. Ascorbic acid supplement during luteal phase in IVF. J Assist Reprod Genet. 2002 Apr;19(4):164-8. PubMed PMID: 12036083; PubMed Central PMCID: PMC3455656.

119: Griesinger G, Saleh L, Bauer S, Husslein P, Knöfler M. Production of pro- and anti-inflammatory cytokines of human placental trophoblasts in response to pathogenic bacteria. J Soc Gynecol Investig. 2001 Nov-Dec;8(6):334-40. PubMed PMID: 11750868.

120: Knöfler M, Saleh L, Bauer S, Vasicek R, Griesinger G, Strohmer H, Helmer H, Husslein P. Promoter elements and transcription factors involved in differentiation-dependent human chorionic gonadotrophin-alpha messenger ribonucleic acid expression of term villous trophoblasts. Endocrinology. 2000 Oct;141(10):3737-48. PubMed PMID: 11014230.

121: Knöfler M, Mösl B, Bauer S, Griesinger G, Husslein P. TNF-alpha/TNFRI in primary and immortalized first trimester cytotrophoblasts. Placenta. 2000 Jul-Aug;21(5-6):525-35. PubMed PMID: 10940203.